KNG1 and COVID-19: Thus, if bradykinin is involved in the genesis of the intense inflammation and microvascular coagulopathy seen in many COVID-19 patients (11, 14, 15), the increase in bradykinin levels that accompanies ARB and neprilyin inhibitor treatment might be harmful.